{
}
Google's DeepMind has unveiled Gemini 2.0, a new AI model designed to power advanced AI agents capable of understanding complex instructions, planning, and executing tasks across various platforms. Projects like Deep Research, Project Astra, and Project Mariner aim to assist users in research, everyday tasks, and web navigation, respectively. While still in early development, these agents show promise for future applications, including gaming and robotics, as Google collaborates with industry leaders to refine their capabilities.
Alphabet reported strong third-quarter earnings, with earnings per share at $2.12 and revenue of $88.27 billion, surpassing expectations. The company saw a 15% year-over-year revenue growth, driven by cloud revenue and YouTube ads, despite facing antitrust challenges and internal restructuring. Key leadership changes were made to enhance its AI capabilities amid increasing competition.
David Baker, Demis Hassabis, and John Jumper have won the Nobel Prize in Chemistry for their groundbreaking work in computational protein design and structure prediction, significantly advancing drug design capabilities. Alnylam Pharmaceuticals seeks FDA approval for vutrisiran to treat a severe form of transthyretin amyloidosis, while Johnson & Johnson halts a bladder cancer trial for TAR-200. AstraZeneca invests in a preclinical cholesterol-lowering drug, and Astellas acquires rights to an experimental gene therapy for frontotemporal dementia.
Demis Hassabis
People
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
google unveils advanced ai agents powered by gemini 2.0 technology
United States Dollar
NVIDIA Corporation
Google Inc.
Salesforce, Inc.
USA
Koray Kavukcuoglu
Marc Benioff
Jensen Huang
Demis Hassabis
Show more
04:38 12.12.2024
alphabet reports strong earnings driven by cloud revenue and ai restructuring
United States Dollar
Alphabet Inc.
Amazon.com, Inc.
Aqua Metals, Inc.
Apple Inc.
Microsoft Corporation
USA
Sundar Pichai
Demis Hassabis
Emily Chang
Prabhakar Raghavan
Nick Fox
Show more
17:00 29.10.2024
nobel prize awarded for protein design and drug developments advance
United States Dollar
Eli Lilly and Company
AviadoBio
Alnylam Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc.
Amgen Inc.
Astellas Pharma Inc.
Pfizer Inc.
BridgeBio Pharma, Inc.
Novartis AG
AstraZeneca PLC
Johnson & Johnson
USA
SWE
JPN
BRA
HKG
John Jumper
David Baker
Jonathan Gardner
Demis Hassabis
Jim Wilson
Show more
13:00 09.10.2024
Trending
Subcategory
Corporate News
Stock Market Updates
Industry Trends
Industry Mergers & Acquisitions
Finance Mergers & Acquisitions
Banking Regulations
Global Trade Developments
Global Financial Events
Domestic Politics
Retail and Consumer Goods
Central Bank Actions
CEO Changes
Government Policies
Market Analysis and Predictions
Startups & Entrepreneurship
Workplace Trends
Elections & Campaigns
Government Economic Policies
Inflation and Monetary Impact
Supply Chain Management
Countries:
Companies:
Tesla, Inc.
JPMorgan Chase & Co.
Barclays PLC
Deutsche Bank Money Market PP
Apple Inc.
UniCredit S.p.A.
Banco BPM S.p.A.
Credit Suisse Strategic Income I
The Goldman Sachs Group, Inc.
SpaceXCoin USD
Lloyds Banking Group plc
BNP Paribas SA
UBS Group AG
Banco Santander, S.A.
CREDIT AGRICOLE
Amazon.com, Inc.
Berkshire Hathaway Inc.
Credit Agricole
Reinsurance Group of America, Incorporated
Google Inc.
Currencies:
United States Dollar
Euro
British Pound Sterling
Swiss Franc
Chinese Yuan
Indian Rupee
Japanese Yen
South Korean Won
Canadian Dollar
Australian Dollar
Offshore Chinese Yuan
Hong Kong Dollar
Singapore Dollar
Mexican Peso
Vietnamese Đồng
Indonesian Rupiah
Thai Baht
Norwegian Krone
Swedish Krona
Filipino Peso
People: